Clinical trial
A Prospective, Observational, Cohort, Multicenter Study of Early Anti-Retroviral Treatment in HIV- Infected Infants
NCT05784584 is registered in ClinicalTrials.gov with PENTA Foundation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Observational, Cohort, Multicenter Study of Early Anti-Retroviral Treatment in HIV- Infected Infants
- Lead sponsor
- PENTA Foundation
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 1, 2018
- Completion date
- March 28, 2024
- Enrollment
- 220 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.